Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICU) Cash from Operations (2023 - 2025)

Historic Cash from Operations for SeaStar Medical Holding (ICU) over the last 3 years, with Q3 2025 value amounting to -$3.8 million.

  • SeaStar Medical Holding's Cash from Operations rose 2315.07% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.2 million, marking a year-over-year increase of 1013.36%. This contributed to the annual value of -$16.0 million for FY2024, which is 5563.44% down from last year.
  • As of Q3 2025, SeaStar Medical Holding's Cash from Operations stood at -$3.8 million, which was up 2315.07% from -$3.0 million recorded in Q2 2025.
  • In the past 5 years, SeaStar Medical Holding's Cash from Operations ranged from a high of -$1.3 million in Q3 2023 and a low of -$5.0 million during Q3 2024
  • Its 3-year average for Cash from Operations is -$3.3 million, with a median of -$3.0 million in 2025.
  • In the last 5 years, SeaStar Medical Holding's Cash from Operations crashed by 27412.12% in 2024 and then soared by 2391.06% in 2025.
  • Quarter analysis of 3 years shows SeaStar Medical Holding's Cash from Operations stood at -$4.5 million in 2023, then decreased by 4.64% to -$4.7 million in 2024, then increased by 18.09% to -$3.8 million in 2025.
  • Its Cash from Operations was -$3.8 million in Q3 2025, compared to -$3.0 million in Q2 2025 and -$2.7 million in Q1 2025.